Clarus Therapeutics Holdings, Inc.
CRXTDelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817944
Clarus Therapeutics Holdings, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Jun 9, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.82M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Clarus Therapeutics Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Clarus Therapeutics Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Prygocki Mark A Sr | Director | 5,766 | Jun 9, 2022 | 0 |
| Cermak Elizabeth | Director | 5,766 | Jun 9, 2022 | 0 |
| Hernandez Joseph | Director | 1,243,266 | Jun 9, 2022 | 0 |
| Murphy Kimberly M | Director | 5,766 | Jun 9, 2022 | 0 |
| Amory John Kenneth | Director | 5,766 | Jun 9, 2022 | 0 |
| Thomas James E | 10% Owner | 3,528Indirect | Apr 25, 2022 | 0 |
| TMP Associates LP | 10% Owner | 3,528Indirect | Apr 25, 2022 | 0 |
| Thomas McNerney & Partners LP | 10% Owner | 3,528Indirect | Apr 25, 2022 | 0 |
| Thomas, McNerney & Partners, LLC | 10% Owner | 3,528Indirect | Apr 25, 2022 | 0 |
| TMP Nominee, LLC | 10% Owner | 3,528Indirect | Apr 25, 2022 | 0 |
| Thomas, McNerney & Partners II L.P. | 10% Owner | 3,528Indirect | Apr 25, 2022 | 0 |
| TMP Associates II LP | 10% Owner | 3,528Indirect | Apr 25, 2022 | 0 |
| TMP Nominee II, LLC | 10% Owner | 3,528Indirect | Apr 25, 2022 | 0 |
| Thomas, McNerney & Partners II, LLC | 10% Owner | 3,528Indirect | Apr 25, 2022 | 0 |
| Peterson Richard D | Chief Financial Officer | 55,800 | Dec 14, 2021 | 0 |
| Bourne Steven A. | Chief Administrative Officer | 30,305 | Dec 14, 2021 | 0 |
| Dudley Robert E. | Chief Executive Officer | 139,566 | Dec 14, 2021 | 0 |
| Jaeger Frank | Chief Commercial Officer | 29,000 | Dec 14, 2021 | 0 |
| Tamer Anthony | 10% Owner | 2,470,756Indirect | Oct 4, 2021 | 0 |
| Mnaymneh Sami | 10% Owner | 2,470,756Indirect | Oct 4, 2021 | 0 |
| H.I.G. Ventures - Clarus, LLC | 10% Owner | 2,470,756Indirect | Oct 4, 2021 | 0 |
| H.I.G.-GPII, Inc. | 10% Owner | 2,470,756Indirect | Oct 4, 2021 | 0 |
| H.I.G. Bio-Clarus I, L.P. | 10% Owner | 2,470,756Indirect | Oct 4, 2021 | 0 |
| H.I.G. Bio-Clarus II, L.P. | 10% Owner | 2,470,756Indirect | Oct 4, 2021 | 0 |
| Blue Water Sponsor LLC | Other: Former 10% owner | 1,302,500Indirect | Sep 23, 2021 | 0 |
| Ffi Fund Ltd | 10% Owner | 2,102,495Indirect | Sep 21, 2021 | 0 |
| FYI Ltd | 10% Owner | 2,102,495Indirect | Sep 21, 2021 | 0 |
| Bracebridge Capital, LLC | 10% Owner | 2,102,495Indirect | Sep 21, 2021 | 0 |
| Olifant Fund, Ltd. | 10% Owner | 2,102,495Indirect | Sep 21, 2021 | 0 |
| Zisson Alex | Director, 10% Owner | 5,692,381Indirect | Sep 13, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2021 (view filing)6:38 PM ET | Sep 17 | 4 days | Ffi Fund Ltd and 3 others10% Owner | SSale | −127.4K | $9.20 | −$1.17M | −5.7%2.10M after | |
| Apr 25, 2022 (view filing)5:17 PM ET | Apr 20 | 5 days | Thomas James E and 8 others10% Owner | SSale | −3.75M | $2.53 | −$9.49M | −99.9%3.53K after | Amended6 lots |